Click to copy
Press release content from Business Wire. The AP news staff was not involved in its creation.
Click to copy
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Insights Into the Global Oligonucleotide Synthesis Market, 2019 to 2024 -- Increasing Use of Synthesized Oligos in Molecular Diagnostics & Clinical Applications - ResearchAndMarkets.com

May 8, 2019

DUBLIN--(BUSINESS WIRE)--May 8, 2019--The “Oligonucleotide Synthesis Market by Product, Type (Custom, Pre design), Application (PCR, DNA, RNAi, Research, Therapeutic), End User - Global Forecast to 2024” report has been added to ResearchAndMarkets.com’s offering.

The global oligonucleotide synthesis market is projected to reach USD 8.2 billion by 2024 from USD 4.3 billion in 2019, at a CAGR of 13.7% during the forecast period.

This market is experiencing significant growth due to the increasing research activities in the pharma and biotech sectors and the rising demand for innovative diagnostic and therapeutic techniques. The increasing applications of oligos in nucleic acid array-based technologies, library preparation, NGS, genomics, nucleic acid-based detection, cell cultures, diagnostics, therapeutics, human identity testing, cloning, genetic engineering, and synthetic biology are also driving the growth of this market.

Hospitals accounted for the largest share of the oligonucleotide synthesis market, by end user, in 2018

Based on end user, the oligonucleotide synthesis market is segmented into academic research institutes, pharmaceutical and biotechnology companies, diagnostic laboratories, and hospitals. Hospitals held the largest share of the market in 2018 due to the significant number of inpatient and outpatient visits in hospitals and the requirement of oligonucleotide drugs to cater to the demand of the patient pool suffering from diseases such as Duchenne muscular dystrophy, spinal muscular atrophy, and hepatic veno-occlusive disease.

Synthesized oligos dominated the oligonucleotide synthesis market, by product, in 2018

Based on product, the market is segmented into synthesized oligos, reagents, and equipment. The synthesized oligos segment held the largest share of the market in 2018 and is estimated to grow at the highest CAGR during the forecast period. Growth in this segment is attributed to the increasing applications of synthesized oligos in therapeutics, research, and diagnostics.

North America to dominate the market during the forecast period

Geographically, the oligonucleotide synthesis market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2018, North America was the largest regional market for oligonucleotide synthesis. The North American market is also estimated to grow at the highest CAGR during the forecast period owing to the growing availability of synthesized oligos, along with an increase in R&D funding and activities in the North American region.

Key Topics Covered

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

4.1 Attractive Opportunities in the Oligonucleotide Synthesis Market

4.2 Synthesized Oligos Market, By Product

4.3 Synthesized Oligos Market, By Type

4.4 Asia Pacific: Oligonucleotide Synthesis Market, By Research Application and Country (2019)

4.5 Oligonucleotide Synthesis Market, By Therapeutic Application

4.6 Oligonucleotide Synthesis Market, By End User

4.7 Geographic Snapshot: Oligonucleotide Synthesis Market

5 Market Overview

5.1 Introduction

5.2 Market Dynamics

5.2.1 Market Drivers Increasing Use of Synthesized Oligos in Molecular Diagnostics and Clinical Applications Increasing Government Investments and R&D Expenditure in Pharmaceutical and Biotechnology Companies Rise in Venture Capital Investments

5.2.2 Market Restraints Price Erosion of Synthesized Oligos Lack of A Unified Set of Regulations for Therapeutic Oligos

5.2.3 Market Opportunities Emerging Asian Markets

5.2.4 Market Challenges Large-Scale Synthesis of Oligos Delivery of Oligonucleotide Drugs to Specific Targets

6 Oligonucleotide Synthesis Market, By Product

6.1 Introduction

6.2 Synthesized Oligos

6.3 Reagents

6.4 Equipment

7 Oligonucleotide Synthesis Market, By Application

7.1 Introduction

7.2 Therapeutic Applications

7.3 Diagnostic Applications

7.4 Research Applications

8 Oligonucleotide Synthesis Market, By End-user

8.1 Introduction

8.2 Hospitals

8.3 Academic Research Institutes

8.4 Pharmaceutical & Biotechnology Companies

8.5 Diagnostic Laboratories

9 Oligonucleotide Synthesis Market, By Region

9.1 Introduction

9.2 North America

9.3 Europe

9.4 Asia Pacific

9.5 Latin America

9.6 Middle East & Africa

10 Competitive Landscape

10.1 Overview

10.2 Market Share Analysis

10.3 Competitive Scenario

10.3.1 Partnerships, Agreements, Contracts, and Collaborations

10.3.2 Product Launches, Upgrades, and Approvals

10.3.3 Expansions

10.3.4 Acquisitions

10.4 Competitive Leadership Mapping (2017)

10.4.1 Vanguards

10.4.2 Innovators

10.4.3 Dynamic Players

10.4.4 Emerging Players

10.5 Competitive Leadership Mapping for Start-Ups (2018)

10.5.1 Progressive Companies

10.5.2 Starting Blocks

10.5.3 Responsive Companies

10.5.4 Dynamic Companies

10.6 MnM Dive-Vendor Comparison Matrix for Start-Ups: Oligonucleotide Synthesis Market

11 Company Profiles

11.1 Agilent Technologies

11.2 ADTBio

11.3 Bioautomation (Acquired by LGC)

11.4 Bio-Synthesis Inc.

11.5 Eurofins Genomics

11.6 Eurogentec

11.7 GE Healthcare

11.8 Genscript

11.9 Genedesign (Part of Ajinomoto

11.10 Integrated DNA Technologies (Acquired by Danaher Corporation)

11.11 LGC Biosearch Technologies

11.12 Merck KGaA

11.13 Nitto Denko Avecia

11.14 Thermo Fisher Scientific

11.15 TriLink Biotechnologies (Part of Maravai Lifesciences)

For more information about this report visit https://www.researchandmarkets.com/r/6bf3al

View source version on businesswire.com:https://www.businesswire.com/news/home/20190508005404/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Genomics



SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 05/08/2019 06:54 AM/DISC: 05/08/2019 06:54 AM


All contents © copyright 2019 The Associated Press. All rights reserved.